Biopharma CEO: ‘No Choice’ But Indy

The chief executive officer of Canada-based POINT Biopharma says location was critical in choosing Indianapolis for its first U.S. manufacturing facility. Dr. Joe McCann says central Indiana's logisti... Read More

KAR Global Details Strategic Investment

Carmel-based KAR Global (NYSE: KAR) has announced a $550 million strategic investment through the placement of newly-issued stock. The vehicle remarketing and technology company says it will use the f... Read More